Charles River Laboratories International Inc (CRL)
227.95
-2.14
(-0.93%)
USD |
NYSE |
May 10, 16:00
227.95
0.00 (0.00%)
After-Hours: 20:00
Charles River Laboratories International Price to Book Value: 3.254 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 3.285 |
May 08, 2024 | 3.359 |
May 07, 2024 | 3.374 |
May 06, 2024 | 3.359 |
May 03, 2024 | 3.333 |
May 02, 2024 | 3.282 |
May 01, 2024 | 3.322 |
April 30, 2024 | 3.269 |
April 29, 2024 | 3.314 |
April 26, 2024 | 3.270 |
April 25, 2024 | 3.252 |
April 24, 2024 | 3.418 |
April 23, 2024 | 3.428 |
April 22, 2024 | 3.320 |
April 19, 2024 | 3.238 |
April 18, 2024 | 3.248 |
April 17, 2024 | 3.285 |
April 16, 2024 | 3.317 |
April 15, 2024 | 3.368 |
April 12, 2024 | 3.445 |
April 11, 2024 | 3.518 |
April 10, 2024 | 3.533 |
April 09, 2024 | 3.671 |
April 08, 2024 | 3.639 |
April 05, 2024 | 3.613 |
Date | Value |
---|---|
April 04, 2024 | 3.578 |
April 03, 2024 | 3.702 |
April 02, 2024 | 3.738 |
April 01, 2024 | 3.836 |
March 28, 2024 | 3.868 |
March 27, 2024 | 3.846 |
March 26, 2024 | 3.790 |
March 25, 2024 | 3.792 |
March 22, 2024 | 3.891 |
March 21, 2024 | 3.904 |
March 20, 2024 | 3.828 |
March 19, 2024 | 3.805 |
March 18, 2024 | 3.742 |
March 15, 2024 | 3.697 |
March 14, 2024 | 3.719 |
March 13, 2024 | 3.729 |
March 12, 2024 | 3.771 |
March 11, 2024 | 3.756 |
March 08, 2024 | 3.811 |
March 07, 2024 | 3.858 |
March 06, 2024 | 3.761 |
March 05, 2024 | 3.730 |
March 04, 2024 | 3.696 |
March 01, 2024 | 3.774 |
February 29, 2024 | 3.629 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.553
Minimum
Oct 30 2023
9.962
Maximum
Sep 24 2021
5.096
Average
4.579
Median
Jun 11 2019
Price to Book Value Benchmarks
Cardinal Health Inc | -- |
Stryker Corp | 6.568 |
DaVita Inc | 13.02 |
IDEXX Laboratories Inc | 26.84 |
Medpace Holdings Inc | 18.00 |
Price to Book Value Related Metrics
PE Ratio | 24.70 |
PS Ratio | 2.841 |
Price to Free Cash Flow | 32.10 |
Price | 227.95 |
Earnings Yield | 4.05% |
Market Cap | 11.71B |
Operating PE Ratio | 19.00 |
Normalized PE Ratio | 24.70 |